Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

por Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2023

Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia

por Mednova, Irina A., Boiko, Anastasiia S., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2022

Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

por Parshukova, Daria A., Smirnova, Liudmila P., Kornetova, Elena G., Semke, Arkadiy V., Buneva, Valentina N., Ivanova, Svetlana A.
Publicado 2020

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients

por Ivanova, Svetlana, Boiko, Anastasia, Bokhan, Nikolay, Fedorenko, Olga, Freidin, Maxim, Loonen, Anton, Osmanova, Diana, Pozhidaev, Ivan, Semke, Arkadiy, Wilffert, Bob
Publicado 2016

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients

por Fattakhov, Nikolai, Smirnova, Liudmila, Atochin, Dmitriy, Parshukova, Daria, Skuratovskaia, Daria, Painter, Quinn, Zatolokin, Pavel, Semke, Arkadiy, Litvinova, Larisa, Ivanova, Svetlana
Publicado 2018

Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome

por Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Goncharova, Anastasiia A., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2022

Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia

por Ermakov, Evgeny A., Smirnova, Ludmila P., Bokhan, Nikolay A., Semke, Arkadiy V., Ivanova, Svetlana A., Buneva, Valentina N., Nevinsky, Georgy A.
Publicado 2017

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

por Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J.M., Ivanova, Svetlana A.
Publicado 2019

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

por Boiko, Anastasiia S, Mednova, Irina A, Kornetova, Elena G, Bokhan, Nikolay A, Semke, Arkadiy V, Loonen, Anton J M, Ivanova, Svetlana A
Publicado 2020

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome

por Mednova, Irina A., Chernonosov, Alexander A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Koval, Vladimir V., Ivanova, Svetlana A.
Publicado 2022

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia

por Mednova, Irina A., Boiko, Anastasiia S., Kornetova, Elena G., Parshukova, Daria A., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Publicado 2020

Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study

por Mednova, Irina A., Chernonosov, Alexander A., Kasakin, Marat F., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Koval, Vladimir V., Ivanova, Svetlana A.
Publicado 2021

Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results

por Mednova, Irina A., Smirnova, Liudmila P., Vasilieva, Alisa R., Kazantseva, Daria V., Epimakhova, Elena V., Krotenko, Nina M., Semke, Arkadiy V., Ivanova, Svetlana A.
Publicado 2022

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia

por Pozhidaev, Ivan V., Paderina, Diana Z., Fedorenko, Olga Yu., Kornetova, Elena G., Semke, Arkadiy V., Loonen, Anton J. M., Bokhan, Nikolay A., Wilffert, Bob, Ivanova, Svetlana A.
Publicado 2020

Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction

por Smirnova, Liudmila P., Yarnykh, Vasily L., Parshukova, Daria A., Kornetova, Elena G., Semke, Arkadiy V., Usova, Anna V., Pishchelko, Anna O., Khodanovich, Marina Y., Ivanova, Svetlana A.
Publicado 2021

The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia

por Poltavskaya, Evgeniya G., Kornetova, Elena G., Freidin, Maxim B., Pozhidaev, Ivan V., Paderina, Diana Z., Bocharova, Anna V., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A., Fedorenko, Olga Y.
Publicado 2023

Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia

por Fedorenko, Olga Yu, Loonen, Anton J. M., Lang, Florian, Toshchakova, Valentina A., Boyarko, Evgenia G., Semke, Arkadiy V., Bokhan, Nikolay A., Govorin, Nikolay V., Aftanas, Lyubomir I., Ivanova, Svetlana A.
Publicado 2015

DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia

por Ermakov, Evgeny A., Smirnova, Ludmila P., Parkhomenko, Taisiya A., Dmitrenok, Pavel S., Krotenko, Nina M., Fattakhov, Nikolai S., Bokhan, Nikolay A., Semke, Arkadiy V., Ivanova, Svetlana A., Buneva, Valentina N., Nevinsky, Georgy A.
Publicado 2015

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia

por Pozhidaev, Ivan V, Boiko, Anastasiia S, Loonen, Anton J M, Paderina, Diana Z, Fedorenko, Olga Yu, Tenin, Gennadiy, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Wilffert, Bob, Ivanova, Svetlana A
Publicado 2020

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

por Paderina, Diana Z., Boiko, Anastasiia S., Pozhidaev, Ivan V., Bocharova, Anna V., Mednova, Irina A., Fedorenko, Olga Yu., Kornetova, Elena G., Loonen, Anton J.M., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2021